Unstable Angina

ELIXA trial shows CV safety of Lixisenatide

In patients with type 2 diabetes and acute coronary syndrome, the glucose-lowering medication lixisenatide did not increase or decrease the rate of cardiovascular (CV) events compared to placebo, according to results of the ...

Aug 31, 2015
popularity9 comments 0

Bioresorbable vascular scaffold deemed noninferior

(HealthDay)—For patients with noncomplex obstructive coronary artery disease, treatment with an everolimus-eluting bioresorbable vascular scaffold is noninferior to treatment with an everolimus-eluting cobalt-chromium stent, ...

Oct 13, 2015
popularity4 comments 0

Cyclosporine does not improve outcomes after PCI

The immunosuppressant drug cyclosporine did not improve clinical outcomes compared to placebo in patients receiving percutaneous coronary intervention (PCI) for the more severe form of heart attack known as ST-segment elevation ...

Aug 30, 2015
popularity47 comments 0

A rare condition of excruciating eye pain

Razor blades. Jabbing needles. Barbed wire. Screaming, howling, red-hot-poker-in-the-eye pain. The impulse to gouge your own eyes out or overdose on sleeping pills – anything to make the pain go away.

Sep 08, 2015
popularity22 comments 0

Unstable angina is a type of angina pectoris that is irregular. It is a type of acute coronary syndrome.

It can be difficult to distinguish from non–Q-wave myocardial infarction.

This text uses material from Wikipedia licensed under CC BY-SA

Latest Spotlight News

Functional human liver cells grown in the lab

In new research appearing in the prestigious journal Nature Biotechnology, an international research team led by The Hebrew University of Jerusalem describes a new technique for growing human hepatocytes in the laboratory. ...

Combination therapy can prevent cytostatic resistance

Researchers at Karolinska Institutet have found a new way of preventing resistance to cytostatics used in the treatment of cancers such as medulloblastoma, the most common form of malignant brain tumour in children. The promising ...